Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors T Pillaiyar, M Manickam, V Namasivayam Journal of Enzyme Inhibition and Medicinal Chemistry 32 (1), 403-425, 2017 | 940 | 2017 |
An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy T Pillaiyar, M Manickam, V Namasivayam, Y Hayashi, SH Jung Journal of medicinal chemistry 59 (14), 6595-6628, 2016 | 828 | 2016 |
Inhibitors of Melanogenesis: An Updated Review T Pillaiyar, V Namasivayam, M Manickam, SH Jung Journal of medicinal chemistry 61 (17), 7395-7418, 2018 | 308 | 2018 |
The journey of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) from lab to clinic V Namasivayam, M Vanangamudi, VG Kramer, S Kurup, P Zhan, X Liu, ... Journal of medicinal chemistry 62 (10), 4851-4883, 2018 | 168 | 2018 |
Overview of recent strategic advances in medicinal chemistry G Wu, T Zhao, D Kang, J Zhang, Y Song, V Namasivayam, J Kongsted, ... Journal of medicinal chemistry 62 (21), 9375-9414, 2019 | 154 | 2019 |
PSO@ Autodock: A fast flexible molecular docking program based on swarm intelligence V Namasivayam, R Günther Chemical biology & drug design 70 (6), 475-484, 2007 | 151 | 2007 |
Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors J Breidenbach, C Lemke, T Pillaiyar, L Schäkel, G Al Hamwi, M Diett, ... Angewandte Chemie International Edition 60 (18), 10423-10429, 2021 | 124 | 2021 |
Characterization of P2X4 receptor agonists and antagonists by calcium influx and radioligand binding studies A Abdelrahman, V Namasivayam, S Hinz, AC Schiedel, M Köse, M Burton, ... Biochemical Pharmacology 125, 41-54, 2017 | 70 | 2017 |
Structure–Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5′-Nucleotidase (CD73) Inhibitors A Junker, C Renn, C Dobelmann, V Namasivayam, S Jain, K Losenkova, ... Journal of medicinal chemistry 62 (7), 3677-3695, 2019 | 64 | 2019 |
The promiscuous ectonucleotidase NPP1: molecular insights into substrate binding and hydrolysis V Namasivayam, SY Lee, CE Mueller Biochimica et Biophysica Acta (BBA)-General Subjects 1861 (3), 603-614, 2017 | 57 | 2017 |
Agonists and antagonists for purinergic receptors CE Müller, Y Baqi, V Namasivayam Purinergic signaling: Methods and protocols, 45-64, 2020 | 55 | 2020 |
Development of Potent and Selective Antagonists for the UTP-Activated P2Y4 Receptor M Rafehi, EM Malik, A Neumann, A Abdelrahman, T Hanck, ... Journal of Medicinal Chemistry 60 (7), 3020-3038, 2017 | 50 | 2017 |
2, 4, 6-Substituted Quinazolines with Extraordinary Inhibitory Potency toward ABCG2 MK Krapf, J Gallus, V Namasivayam, M Wiese Journal of medicinal chemistry 61 (17), 7952-7976, 2018 | 43 | 2018 |
Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y2 Receptor M Rafehi, A Neumann, Y Baqi, EM Malik, M Wiese, V Namasivayam, ... Journal of medicinal chemistry 60 (20), 8425-8440, 2017 | 42 | 2017 |
Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief overview of clinically approved drugs and combination regimens M Vanangamudi, S Kurup, V Namasivayam Current Opinion in Pharmacology 54, 179-187, 2020 | 41 | 2020 |
Fluorescent-Labeled Selective Adenosine A2B Receptor Antagonist Enables Competition Binding Assay by Flow Cytometry M Kose, S Gollos, T Karcz, A Fiene, F Heisig, A Behrenswerth, ... Journal of medicinal chemistry 61 (10), 4301-4316, 2018 | 40 | 2018 |
Substrate-dependence of competitive nucleotide pyrophosphatase/phosphodiesterase1 (NPP1) inhibitors SY Lee, S Sarkar, S Bhattarai, V Namasivayam, S De Jonghe, H Stephan, ... Frontiers in Pharmacology 8, 54, 2017 | 40 | 2017 |
MAS-related G protein-coupled receptors X (MRGPRX): Orphan GPCRs with potential as targets for future drugs G Al Hamwi, YK Riedel, S Clemens, V Namasivayam, D Thimm, ... Pharmacology & Therapeutics 238, 108259, 2022 | 39 | 2022 |
Cancer cells adapt FAM134B/BiP mediated ER-phagy to survive hypoxic stress S Chipurupalli, R Ganesan, G Martini, L Mele, A Reggio, M Esposito, ... Cell Death & Disease 13 (4), 357, 2022 | 38 | 2022 |
Thioesterase-mediated side chain transesterification generates potent Gq signaling inhibitor FR900359 C Hermes, R Richarz, DA Wirtz, J Patt, W Hanke, S Kehraus, JH Voß, ... Nature communications 12 (1), 144, 2021 | 38 | 2021 |